Authors

Judith Krens

Partner

Read More

Matthew Royle, Ph.D.

Partner

Read More

Dr. Nora E. Wessendorf, LL.M. (Washington)

Senior associate

Read More
Authors

Judith Krens

Partner

Read More

Matthew Royle, Ph.D.

Partner

Read More

Dr. Nora E. Wessendorf, LL.M. (Washington)

Senior associate

Read More

25 November 2020 | 59:21

Biologics and biosimilars litigation update

Catch up on the third and final webinar in our 2020 series on decisions in the United States and Europe impacting biologics and biosimilars.

Many of the top-selling drugs worldwide are biologics and several companies are seeking to produce biosimilars to compete in these lucrative markets. However, companies continue to face a great deal of uncertainty due to unresolved legal questions involving the governing statutes and patent rights.

Session 3 focuses on recent key developments in the United States and Europe, including:

  • Recent decisions and developments in the United States which may impact biologics and biosimilars, including Arthrex v Smith & Nephew, AAM v Becerra, and GSK v Teva.
  • Recent decisions and developments in Europe, including the Santen CJEU decision, enforcement of personalised medicine claims, and the UK’s guidelines for biosimilars post Brexit. 
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

centrifuge-machine
Life sciences & healthcare

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27 July 2020
QUICK READ

by multiple authors

Click here to find out more
woman-with-scientific-model
Life sciences & healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 April 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

Biosimilars – The economics of biosimilars: Market access, pricing and legal considerations

17 December 2019

by Matthew Royle, Ph.D.

Click here to find out more

Related events

There are no upcoming events